The survivin:Fas ratio is predictive of recurrent disease in neuroblastoma.
Authors:
- Anthony SandlerASAnthony Sandler
- David ScottDSDavid Scott
- Takeo AzuhataTATakeo Azuhata
- Shigeru TakamizawaSTShigeru Takamizawa
- Sue O'DorisioSOSue O'Dorisio
- 1 March 2002
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 37 (3) , 507-511